跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 35 条关于
“Psilera”
全部
35
临床试验
20
药物
0
机构
2
资讯
13
5年前
Psilera Partners with Worldwide for Accelerated Clinical Development of DMT Patch
22天前
Psilera Appoints Neuroscience Veteran Allyson Gage, PhD, to Lead Phase 1 Trial of Neuroplastogen PSIL-006
去年
Psilera Partners with Hesperos to Advance Organ-on-a-Chip Testing for Frontotemporal Dementia Drug
2年前
Psilera's PSIL-006 Shows Promise in Treating Frontotemporal Dementia Without Hallucinogenic Effects
去年
Kailera Therapeutics Launches with $400M to Advance GLP-1 Based Obesity Therapies
去年
Kailera Bio Obtains $400M to Fast-Track Obesity Drug into Phase 3 Trials
9个月前
PsiThera Raises $47.5 Million Series A to Develop Oral Drugs for TNF Superfamily Targets
去年
Kailera's HRS9531 Shows Strong Phase II Weight Loss, Pfizer Cautious on Danuglipron
4个月前
Kailera and Hengrui Present Promising Ribupatide Data at ADA 2026, Demonstrating Strong Weight Loss Efficacy
11个月前
Kailera Therapeutics Secures $600M Series B to Advance Obesity Drug KAI-9531 to Phase 3 Trials
第 1 页,共 2 页
上一页
下一页